Skip to main content

Advertisement

Table 4 Adherence comparison between participants/non-participants and participants with reliable EM data and participant dropouts

From: Examining assumptions regarding valid electronic monitoring of medication therapy: development of a validation framework and its application on a European sample of kidney transplant patients

  Variable Subgroups
Non-participants   Non-participants Participants
   median iqr b n median iqr n
  Self-report a 0.0 0.0 65 0.0 0.0 284
  Collateral report a 1.0 0.1 35 1.0 0.3 164
  Assay: cyclosporine (mmol/l) 112.5 50.0 50 105.0 56.0 191
  Assay: tacrolimus (mmol/l) 7.6 3.2 21 7.2 3.9 44
  Assay: sirolimus (mmol/l) 14.3 4.2 5 8.8 9.5 15
  Assay: mycophenolate mofetil (mmol/l) 3.3 1.8 41 2.6 1.9 122
Dropouts   Non-adherers to the EM guidelines Adherers to the EM-guidelines
   median iqr n median iqr n
  Self-report 0.0 0.0 36 0.0 0.0 244
  Collateral report 1.0 0.7 35 1.0 0.3 224
  Assay: cyclosporine (mmol/l) 108.0 43.0 25 104.5 58.5 164
  Assay: tacrolimus (mmol/l) 6.2 6.1 5 7.2 3.7 39
  Assay: mycophenolate mofetil (mmol/l) 2.7 1.8 17 2.6 1.9 101
  1. a Definition: see section variables and measurement
  2. b Interquartile range